Frangou E, Bertelli G, Love S, Mackean M J, Glasspool R M, Fotopoulou C, Cook A, Nicum S, Lord R, Ferguson M, Roux R L, Martinez M, Butcher C, Hulbert-Williams N, Howells L, Blagden S P
Centre for Statistics and Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; MRC Clinical Trials Unit at UCL, London, UK.
Sussex Cancer Centre, Brighton, UK.
Gynecol Oncol. 2021 Aug;162(2):431-439. doi: 10.1016/j.ygyno.2021.05.024. Epub 2021 May 29.
Fear of disease progression (FOP) is a rational concern for women with Ovarian Cancer (OC) and depression is also common. To date there have been no randomized trials assessing the impact of psychological intervention on depression and FOP in this patient group.
Patients with primary or recurrent OC who had recently completed chemotherapy were eligible if they scored between 5 and 19 on the PHQ-9 depression and were randomized 1:1 to Intervention (3 standardized CBT-based sessions in the 6-12 weeks post-chemotherapy) or Control (standard of care). PHQ-9, FOP-Q-SF, EORTC QLQ C30 and OV28 questionnaires were then completed every 3 months for up to 2 years. The primary endpoint was change in PHQ-9 at 3 months. Secondary endpoints were change in other scores at 3 months and all scores at later timepoints.
182 patients registered; 107 were randomized; 54 to Intervention and 53 to Control; mean age 59 years; 75 (70%) had completed chemotherapy for primary and 32 (30%) for relapsed OC and 67 patients completed both baseline and 3-month questionnaires. Improvement in PHQ-9 was observed for patients in both study arms at three months compared to baseline but there was no significant difference in change between Intervention and Control. A significant improvement on FOP-Q-SF scores was seen in the Intervention arm, whereas for those in the Control arm FOP-Q-SF scores deteriorated at 3 months (intervention effect = -4.4 (-7.57, -1.22), p-value = 0.008).
CBT-based psychological support provided after chemotherapy did not significantly alter the spontaneously improving trajectory of depression scores at three months but caused a significant improvement in FOP. Our findings call for the routine implementation of FOP support for ovarian cancer patients.
对疾病进展的恐惧(FOP)是卵巢癌(OC)女性患者的合理担忧,且抑郁症也很常见。迄今为止,尚无随机试验评估心理干预对该患者群体抑郁症和FOP的影响。
近期完成化疗的原发性或复发性OC患者,若其PHQ-9抑郁量表得分在5至19分之间,则符合入选条件,并按1:1随机分为干预组(化疗后6至12周进行3次标准化的基于认知行为疗法的疗程)或对照组(标准治疗)。然后每3个月完成一次PHQ-9、FOP-Q-SF、EORTC QLQ C30和OV28问卷,为期2年。主要终点是3个月时PHQ-9的变化。次要终点是3个月时其他分数的变化以及后期时间点的所有分数。
182名患者登记;107名被随机分组;54名进入干预组,53名进入对照组;平均年龄59岁;75名(70%)完成了原发性OC化疗,32名(30%)完成了复发性OC化疗,67名患者完成了基线和3个月问卷。与基线相比,两组患者在3个月时PHQ-9均有改善,但干预组和对照组之间的变化无显著差异。干预组FOP-Q-SF评分有显著改善,而对照组患者在3个月时FOP-Q-SF评分恶化(干预效应=-4.4(-7.57,-1.22),p值=0.008)。
化疗后提供的基于认知行为疗法(CBT)的心理支持在3个月时并未显著改变抑郁症评分自发改善的轨迹,但显著改善了FOP。我们的研究结果呼吁对卵巢癌患者常规实施FOP支持。